Sample Analysis – Itemized Laboratory Services and Fees Sample Clauses

Sample Analysis – Itemized Laboratory Services and Fees. FGF19 Assay Estimated # of slides or blocks Cost per Test Projected Total Slide/block accessioning fee per case […***…] […***…] […***…] H&E Stain […***…] […***…] […***…] H&E Pathology Review […***…] […***…] […***…] IHC Negative Control (non-immune IgG) Staining […***…] […***…] […***…] IHC Negative Control – Pathology Score […***…] […***…] […***…] FGF19 IHC Staining […***…] […***…] […***…] Confidential and Proprietary Information of Ventana and Blueprint Medicines Staining and Pathology Testing Charges Estimated # of slides or blocks Cost per Test Projected Total FGF19 IHC Pathology Score (Total Percent of Positive Tumor Cells) […***…] […***…] […***…] Clinical Sample Image – Scan* *Image capture and scan; PER STAIN upon request only, e.g., just FGF19 positives […***…] […***…] […***…] PROJECTED SUB TOTAL […***…] Total CAP/CLIA Laboratory Cost Category Projected Cost Assay Access Fee No Charge CAP/CLIA Lab Itemized Fixed Costs $ […***…] Clinical Sample Analysis $ […***…] Total $ […***…] Payment Terms: Invoiced monthly after completion of sample analysis. For the avoidance of doubt, Blueprint Medicines will only be charged for the actual, not estimated, services performed as described herein. All invoices should contain the following information in order for them to be processed efficiently:  Invoice NumberInvoice DateReference to <agreed to reference point>  Blueprint Medicines, Purchase Order Number (PO#)  Blueprint Medicines, Project Number <may be redundant>  Description of Services with Itemization: Stage and milestone identifications  Deliverables  Total Amount Due  Payee Name and Tax ID Number  Payment Address  Name of requisitioner  Contact person for any invoice questions Additionally, invoices shall be submitted to Blueprint at the following email address: xx@xxxxxxxxxxxxxxxxxx.xxx. All invoices will be paid by Blueprint Medicines as follows: Credit DDA Name: Ventana Medical Systems, Inc. Tax Payer ID#: […***…] Address: […***…] Credit Bank: […***…] Credit Bank address […***…] Credit ABA: […***…] Credit: DDA […***…] Citi SWIFT Code: […***…] Confidential and Proprietary Information of Ventana and Blueprint Medicines Pass Through Expenses The following expenses will be billed as needed and agreed by the parties: Tissue Acquisition: This work does not require tissue acquisition by Ventana. Other: Any unforeseen project related expenses incurred by Ventana will be discussed in good faith by the Parties and agreed to prior to Ventana submit...
Sample 1
AutoNDA by SimpleDocs

Related to Sample Analysis – Itemized Laboratory Services and Fees

  • Commercialization Reports After the First Commercial Sale of a Licensed Product anywhere in the Territory, LICENSEE shall submit to Cornell semi-annual reports on or before each February 28 and August 31 of each year. Each report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar half-year and shall show:

  • Quantitative Analysis Quantitative analysts develop and apply financial models designed to enable equity portfolio managers and fundamental analysts to screen potential and current investments, assess relative risk and enhance performance relative to benchmarks and peers. To the extent that such services are to be provided with respect to any Account which is a registered investment company, Categories 3, 4 and 5 above shall be treated as “investment advisory services” for purposes of Section 5(b) of the Agreement.”

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Independent Analysis Each Party hereby confirms that its decision to execute this Agreement has been based upon its independent assessment of documents and information available to it, as it has deemed appropriate.

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall:

  • Manufacturing Costs In the event of termination by Merck pursuant to Section 6.2, 6.3 or 6.6 above, Merck shall be entitled to [*****] (as defined herein) incurred by Merck for its Compound Delivered for the Study. [*****]

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Development Activities NovaDel shall not be required to commence any Development Activities until Licensee has paid at least twenty-five percent (25%) of the non-refundable License Fee described in Section 4.4.

  • Escrow Analysis If applicable, with respect to each Mortgage Loan, the Seller has within the last twelve months (unless such Mortgage was originated within such twelve month period) analyzed the required Escrow Payments for each Mortgage and adjusted the amount of such payments so that, assuming all required payments are timely made, any deficiency will be eliminated on or before the first anniversary of such analysis, or any overage will be refunded to the Mortgagor, in accordance with RESPA and any other applicable law;

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

Time is Money Join Law Insider Premium to draft better contracts faster.